Literature DB >> 8155441

Monitoring neuromuscular block by acceleromyography: comparison of the Mini-Accelograph with the Myograph 2000.

N J Harper1, R Martlew, T Strang, M Wallace.   

Abstract

The precision of the compact Mini-Accelograph (M-A) was compared with the Myograph 2000 (MYO). Neuromuscular block resulting from atracurium was measured simultaneously by the MYO and the M-A applied to contralateral thumbs. During onset, the M-A frequently underestimated the extent of block (maximal at approximately 50% twitch depression). The M-A control train-of-four (TOF) ratio was characteristically > 1.0 and remained greater than the MYO ratio during the onset of atracurium. During recovery, the difference between the MYO and the M-A was maximal at approximately 50% twitch depression, but the M-A frequently overestimated the extent of block. The mean differences between the MYO and the M-A were small in respect of the recovery index (RI) and the TOF. However, the limits of agreement were unacceptably wide for both TOF and RI. When the MYO TOF was 0.7, the corresponding M-A TOF varied between 0.4 and 1.0. The M-A was more susceptible to drift than the MYO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8155441     DOI: 10.1093/bja/72.4.411

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Mindray 3-directional NMT Module (a new generation "Tri-axial" neuromuscular monitor) versus the Relaxometer mechanomyograph and versus the TOF-Watch SX acceleromyograph.

Authors:  Ashraf A Dahaba; Ismet Suljevic; Zhao Yang Xiao; Kun Wang
Journal:  J Clin Monit Comput       Date:  2018-12-05       Impact factor: 2.502

2.  Positive and negative staircase effect during single twitch and train-of-four stimulation: a laboratory study in dogs.

Authors:  Manuel Martin-Flores; Chia T Tseng; Daniel M Sakai; Marta Romano; Luis Campoy; Robin D Gleed
Journal:  J Clin Monit Comput       Date:  2016-02-16       Impact factor: 2.502

Review 3.  [Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies].

Authors:  T Fuchs-Buder; M Eikermann
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

4.  Acceleromyography improves detection of residual neuromuscular blockade in children.

Authors:  J M Ansermino; P M Sanderson; J C Bevan; D R Bevan
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

Review 5.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

6.  New equipment for neuromuscular transmission monitoring: a comparison of the TOF-Guard with the Myograph 2000.

Authors:  H Kirkegaard-Nielsen; H S Helbo-Hansen; P Lindholm; H S Pedersen; I K Severinsen; M B Schmidt
Journal:  J Clin Monit Comput       Date:  1998-01       Impact factor: 2.502

7.  Influence of tetanic stimulation on the staircase phenomenon and the acceleromyographic time-course of neuromuscular block: a randomized controlled trial.

Authors:  Guido Mazzinari; Carlos L Errando; Oscar Díaz-Cambronero; Manuel Martin-Flores
Journal:  J Clin Monit Comput       Date:  2018-05-18       Impact factor: 2.502

8.  The construction and evaluation of a device for mechanomyography in anaesthetized Göttingen minipigs.

Authors:  R Eddie Clutton; Kosala Dissanayake; Holly Lawson; Keith Simpson; Adrian Thompson; Michael Eddleston
Journal:  Vet Anaesth Analg       Date:  2012-07-13       Impact factor: 1.648

9.  A comparison of the accuracy of ulnar versus median nerve stimulation for neuromuscular monitoring.

Authors:  Hee Jong Lee; Kyo Sang Kim; Jae Chul Shim; Sung Wook Yoon
Journal:  Korean J Anesthesiol       Date:  2011-05-31

10.  Recovery of post-tetanic and train-of-four responses at the first dorsal interosseous and adductor pollicis muscles in patients receiving vecuronium.

Authors:  Y Saitoh; H Tanaka; H Toyooka; K Amaha
Journal:  Can J Anaesth       Date:  1996-04       Impact factor: 6.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.